載入...
Treatment of Isoniazid-Resistant Pulmonary Tuberculosis
Tuberculosis (TB) remains a threat to public health and is the leading cause of death globally. Isoniazid (INH) is an important first-line agent for the treatment of TB considering its early bactericidal activity. Resistance to INH is now the most common type of resistance. Resistance to INH reduces...
Na minha lista:
| 發表在: | Tuberc Respir Dis (Seoul) |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6953491/ https://ncbi.nlm.nih.gov/pubmed/31905429 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4046/trd.2019.0065 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|